Search
Pulmonary Fibrosis Clinical Trials in Birmingham, AL
A listing of 13 Pulmonary Fibrosis clinical trials in Birmingham, AL actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
13 - 13 of 13
The city of Birmingham, Alabama, currently has 13 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Irritability Associated with Autism (Children and Adolescents) Study
Recruiting
Sign up for a clinical trial today and contribute to the advancement of medical research, paving the way for innovative treatments. Receive financial compensation for your participation and benefit from complimentary medical care.
Featured Trial
KALOS
Recruiting
The KALOS study is evaluating if an investigational inhaler called BGF MDI may provide benefit for people whose asthma symptoms are not fully controlled using their current inhaler treatment.
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Recruiting
The purpose of the study is to see if imaging with fluorine-18 Fluorodeoxyglucose ([18F] FDG) and fluorine-18 Displacement Per Atom ([18F]DPA-714) using positron emission tomography and computed tomography (PET/CT) will show lung inflammation and fibrosis in patients diagnosed with idiopathic pulmonary fibrosis (IPF). This study may help physicians and researchers better understand how best to treat patients with IPF in the future.
Gender:
All
Ages:
Between 40 years and 85 years
Trial Updated:
06/29/2023
Locations: The University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Idiopathic Pulmonary Fibrosis
13 - 13 of 13